C-Path Receives FDA Qualification for the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) TUCSON, Ariz., March 9, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces the
C-Path and Global Partners Launch Ataxia Consortium The Critical Path to Therapeutics for the Ataxias will optimize clinical trials for inherited ataxias TUCSON, Ariz., Febru
C-Path Appoints Co-Directors to CURE Drug Repurposing Collaboratory Advisory Committee TUCSON, Ariz., February 4, 2021 — Critical Path Institute (C-Path) today has announced the appointments of David F
C-Path Announces SHIP-MD 2021 Virtual Workshop Multi-stakeholder event will focus on national innovation ecosystem for pediatric medical device development TUCSON, Ariz.,
Diary for Irritable Bowel Syndrome Symptoms-Constipation is the First Patient-Reported Outcome Consortium Measure Used to Support an FDA-approved Label Claim TUCSON, Ariz., January 7, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces th
C-Path and Diamyd Medical Announce Data Sharing Collaboration to Develop Advanced Drug Development Tools in Type 1 Diabetes TUCSON, Ariz., and STOCKHOLM, Sweden. December 16, 2020 — The Critical Path Institute (C-Path) and Diamyd Medical
December 3, 2020 C-Path Selects Aridhia to Support Rare Disease Cures Accelerator-Data and Analytics Platform TUCSON, Ariz., December 3, 2020 — The Critical Path Institute (C-Path) today announced it has selected Aridhia to support
C-Path, Ltd. Announces New Contract with Innovative Medicines Initiative DUBLIN, Ireland, December 3, 2020 — Critical Path Institute, Ltd. (C-Path, Ltd.) announced today a new contract with the
C-Path Quantitative Medicine Program Awarded FDA Contract to Develop Tools for Neuroscience Diseases TUCSON, Ariz., December 2, 2020 — The Critical Path Institute (C-Path) today announced it has been awarded a U.S. Food an
Alzheimer’s Disease Data Initiative Launches, Critical Path for Alzheimer’s Disease Consortium to Partner CPAD will partner with ADDI to build better tools for researchers around the world to access, use and share dementia-relate